PUBLISHER: KBV Research | PRODUCT CODE: 1309478
PUBLISHER: KBV Research | PRODUCT CODE: 1309478
Europe Helicobacter Pylori Diagnostics Market Size, Share & Industry Trends Analysis Report By Test Type (Non-invasive and Invasive), By End User, By Method (Laboratory Based Test and Point of Care Test), By Country and Growth Forecast, 2023 - 2030
The Europe Helicobacter Pylori Diagnostics Market would witness market growth of 5.3% CAGR during the forecast period (2023-2030).
The market is expanding as a result of rising demand for non-invasive diagnostics. Patients favor non-invasive diagnostic procedures such as stool antigen and breath testing over invasive procedures like endoscopy. Because of this, new diagnostic technologies have been developed in response to the demand for non-invasive tests, which will continue to fuel the expansion of the market. Due to the availability of enhanced healthcare infrastructure, an increase in unmet healthcare demands, and an increase in infectious disorders, the market is anticipated to grow rapidly.
Additionally, the desire for better healthcare services, large government investments in enhancing the infrastructure for healthcare, and the growth of the medical tourism sector in emerging nations are all contributing to the significant growth of the healthcare sector in developing nations. Additionally, diagnosis of H. pylori infections early and treating them can help avoid more significant side effects like stomach cancer, which can encourage market expansion. There is a rise in requirement for H. pylori testing to aid in early detection and treatment. Also, when people become more aware of these disorders, there will be an increase in the need for H. pylori diagnostic, which will aid the growth of the market.
Gastrointestinal sickness ranking as the third most prevalent cause of mortality, the number one cause of cancer death, and the most frequent reason for hospital admission, the burden of gastrointestinal and liver disease is heavy on patients, the NHS, and the economy. Most gastrointestinal disorders are now more common, which has a substantial impact on future healthcare needs. Hepatitis C infections, acute and chronic pancreatitis, alcoholic liver disease, upper gastrointestinal bleeding, Barrett's esophagus, and colorectal and oesophageal malignancies are among these illnesses. The region's market will increase rapidly due to the increasing prevalence of stomach cancer and other gastrointestinal illnesses, which will surge the demand for diagnosis in Europe.
The Germany market dominated the Europe Helicobacter Pylori Diagnostics Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $53.3 Million by 2030. The UK market is anticipated to grow at a CAGR of 4.5% during (2023 - 2030). Additionally, The France market would showcase a CAGR of 6.1% during (2023 - 2030).
Based on Test Type, the market is segmented into Non-invasive and Invasive. Based on End User, the market is segmented into Diagnostics Laboratories, Hospitals, and Others. Based on Method, the market is segmented into Laboratory Based Test and Point of Care Test. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Cardinal Health, Inc., Biohit Oyj, Abbott Laboratories, Quidel Corporation, Gulf Coast Scientific, Inc. (Gulf Coast Medical Center), Meridian Bioscience, Inc. (SD Biosensor Co., Ltd.), Avanos Medical, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc. and F. Hoffmann-La Roche Ltd.
Scope of the Study
Market Segments covered in the Report:
By Test Type
- Non-invasive
- Invasive
By End User
- Diagnostics Laboratories
- Hospitals
- Others
By Method
- Laboratory Based Test
- Point of Care Test
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Companies Profiled
- Cardinal Health, Inc.
- Biohit Oyj
- Abbott Laboratories
- Quidel Corporation
- Gulf Coast Scientific, Inc. (Gulf Coast Medical Center)
- Meridian Bioscience, Inc. (SD Biosensor Co., Ltd.)
- Avanos Medical, Inc.
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche Ltd.
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Helicobacter Pylori Diagnostics Market, by Test Type
- 1.4.2 Europe Helicobacter Pylori Diagnostics Market, by End User
- 1.4.3 Europe Helicobacter Pylori Diagnostics Market, by Method
- 1.4.4 Europe Helicobacter Pylori Diagnostics Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market composition & scenario
- 2.1.1 Overview
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
Chapter 3. Europe Helicobacter Pylori Diagnostics Market by Test Type
- 3.1 Europe Non-invasive Market by Country
- 3.2 Europe Invasive Market by Country
Chapter 4. Europe Helicobacter Pylori Diagnostics Market by End User
- 4.1 Europe Diagnostics Laboratories Market by Country
- 4.2 Europe Hospitals Market by Country
- 4.3 Europe Others Market by Country
Chapter 5. Europe Helicobacter Pylori Diagnostics Market by Method
- 5.1 Europe Laboratory Based Test Market by Country
- 5.2 Europe Point of Care Test Market by Country
Chapter 6. Europe Helicobacter Pylori Diagnostics Market by Country
- 6.1 Germany Helicobacter Pylori Diagnostics Market
- 6.1.1 Germany Helicobacter Pylori Diagnostics Market by Test Type
- 6.1.2 Germany Helicobacter Pylori Diagnostics Market by End User
- 6.1.3 Germany Helicobacter Pylori Diagnostics Market by Method
- 6.2 UK Helicobacter Pylori Diagnostics Market
- 6.2.1 UK Helicobacter Pylori Diagnostics Market by Test Type
- 6.2.2 UK Helicobacter Pylori Diagnostics Market by End User
- 6.2.3 UK Helicobacter Pylori Diagnostics Market by Method
- 6.3 France Helicobacter Pylori Diagnostics Market
- 6.3.1 France Helicobacter Pylori Diagnostics Market by Test Type
- 6.3.2 France Helicobacter Pylori Diagnostics Market by End User
- 6.3.3 France Helicobacter Pylori Diagnostics Market by Method
- 6.4 Russia Helicobacter Pylori Diagnostics Market
- 6.4.1 Russia Helicobacter Pylori Diagnostics Market by Test Type
- 6.4.2 Russia Helicobacter Pylori Diagnostics Market by End User
- 6.4.3 Russia Helicobacter Pylori Diagnostics Market by Method
- 6.5 Spain Helicobacter Pylori Diagnostics Market
- 6.5.1 Spain Helicobacter Pylori Diagnostics Market by Test Type
- 6.5.2 Spain Helicobacter Pylori Diagnostics Market by End User
- 6.5.3 Spain Helicobacter Pylori Diagnostics Market by Method
- 6.6 Italy Helicobacter Pylori Diagnostics Market
- 6.6.1 Italy Helicobacter Pylori Diagnostics Market by Test Type
- 6.6.2 Italy Helicobacter Pylori Diagnostics Market by End User
- 6.6.3 Italy Helicobacter Pylori Diagnostics Market by Method
- 6.7 Rest of Europe Helicobacter Pylori Diagnostics Market
- 6.7.1 Rest of Europe Helicobacter Pylori Diagnostics Market by Test Type
- 6.7.2 Rest of Europe Helicobacter Pylori Diagnostics Market by End User
- 6.7.3 Rest of Europe Helicobacter Pylori Diagnostics Market by Method
Chapter 7. Company Profiles
- 7.1 Biohit Oyj
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Regional Analysis
- 7.1.4 Research & Development Expenses
- 7.2 Gulf Coast Scientific, Inc. (Gulf Coast Medical Center)
- 7.2.1 Company Overview
- 7.3 Meridian Bioscience, Inc. (SD Biosensor Co., Ltd.)
- 7.3.1 Company Overview
- 7.3.2 Financial Analysis
- 7.3.3 Recent strategies and developments:
- 7.3.3.1 Acquisition and Mergers:
- 7.4 Avanos Medical, Inc.
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Regional Analysis
- 7.4.4 Research & Development Expenses
- 7.5 Abbott Laboratories
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Segmental and Regional Analysis
- 7.5.4 Research & Development Expense
- 7.5.5 SWOT Analysis
- 7.6 Thermo Fisher Scientific, Inc.
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Segmental and Regional Analysis
- 7.6.4 Research & Development Expenses
- 7.6.5 SWOT Analysis
- 7.7 F. Hoffmann-La Roche Ltd.
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Segmental and Regional Analysis
- 7.7.4 Research & Development Expense
- 7.8 Quidel Corporation
- 7.8.1 Company Overview
- 7.8.2 Financial Analysis
- 7.8.3 Regional Analysis
- 7.8.4 Research & Development Expense
- 7.9 Cardinal Health, Inc.
- 7.9.1 Company Overview
- 7.9.2 Financial Analysis
- 7.9.3 Segmental and Regional Analysis
- 7.10. Bio-Rad laboratories, Inc.
- 7.10.1 Company Overview
- 7.10.2 Financial Analysis
- 7.10.3 Segmental and Regional Analysis
- 7.10.4 Research & Development Expenses
LIST OF TABLES
- TABLE 1 Europe Helicobacter Pylori Diagnostics Market, 2019 - 2022, USD Million
- TABLE 2 Europe Helicobacter Pylori Diagnostics Market, 2023 - 2030, USD Million
- TABLE 3 Europe Helicobacter Pylori Diagnostics Market by Test Type, 2019 - 2022, USD Million
- TABLE 4 Europe Helicobacter Pylori Diagnostics Market by Test Type, 2023 - 2030, USD Million
- TABLE 5 Europe Non-invasive Market by Country, 2019 - 2022, USD Million
- TABLE 6 Europe Non-invasive Market by Country, 2023 - 2030, USD Million
- TABLE 7 Europe Invasive Market by Country, 2019 - 2022, USD Million
- TABLE 8 Europe Invasive Market by Country, 2023 - 2030, USD Million
- TABLE 9 Europe Helicobacter Pylori Diagnostics Market by End User, 2019 - 2022, USD Million
- TABLE 10 Europe Helicobacter Pylori Diagnostics Market by End User, 2023 - 2030, USD Million
- TABLE 11 Europe Diagnostics Laboratories Market by Country, 2019 - 2022, USD Million
- TABLE 12 Europe Diagnostics Laboratories Market by Country, 2023 - 2030, USD Million
- TABLE 13 Europe Hospitals Market by Country, 2019 - 2022, USD Million
- TABLE 14 Europe Hospitals Market by Country, 2023 - 2030, USD Million
- TABLE 15 Europe Others Market by Country, 2019 - 2022, USD Million
- TABLE 16 Europe Others Market by Country, 2023 - 2030, USD Million
- TABLE 17 Europe Helicobacter Pylori Diagnostics Market by Method, 2019 - 2022, USD Million
- TABLE 18 Europe Helicobacter Pylori Diagnostics Market by Method, 2023 - 2030, USD Million
- TABLE 19 Europe Laboratory Based Test Market by Country, 2019 - 2022, USD Million
- TABLE 20 Europe Laboratory Based Test Market by Country, 2023 - 2030, USD Million
- TABLE 21 Europe Point of Care Test Market by Country, 2019 - 2022, USD Million
- TABLE 22 Europe Point of Care Test Market by Country, 2023 - 2030, USD Million
- TABLE 23 Europe Helicobacter Pylori Diagnostics Market by Country, 2019 - 2022, USD Million
- TABLE 24 Europe Helicobacter Pylori Diagnostics Market by Country, 2023 - 2030, USD Million
- TABLE 25 Germany Helicobacter Pylori Diagnostics Market, 2019 - 2022, USD Million
- TABLE 26 Germany Helicobacter Pylori Diagnostics Market, 2023 - 2030, USD Million
- TABLE 27 Germany Helicobacter Pylori Diagnostics Market by Test Type, 2019 - 2022, USD Million
- TABLE 28 Germany Helicobacter Pylori Diagnostics Market by Test Type, 2023 - 2030, USD Million
- TABLE 29 Germany Helicobacter Pylori Diagnostics Market by End User, 2019 - 2022, USD Million
- TABLE 30 Germany Helicobacter Pylori Diagnostics Market by End User, 2023 - 2030, USD Million
- TABLE 31 Germany Helicobacter Pylori Diagnostics Market by Method, 2019 - 2022, USD Million
- TABLE 32 Germany Helicobacter Pylori Diagnostics Market by Method, 2023 - 2030, USD Million
- TABLE 33 UK Helicobacter Pylori Diagnostics Market, 2019 - 2022, USD Million
- TABLE 34 UK Helicobacter Pylori Diagnostics Market, 2023 - 2030, USD Million
- TABLE 35 UK Helicobacter Pylori Diagnostics Market by Test Type, 2019 - 2022, USD Million
- TABLE 36 UK Helicobacter Pylori Diagnostics Market by Test Type, 2023 - 2030, USD Million
- TABLE 37 UK Helicobacter Pylori Diagnostics Market by End User, 2019 - 2022, USD Million
- TABLE 38 UK Helicobacter Pylori Diagnostics Market by End User, 2023 - 2030, USD Million
- TABLE 39 UK Helicobacter Pylori Diagnostics Market by Method, 2019 - 2022, USD Million
- TABLE 40 UK Helicobacter Pylori Diagnostics Market by Method, 2023 - 2030, USD Million
- TABLE 41 France Helicobacter Pylori Diagnostics Market, 2019 - 2022, USD Million
- TABLE 42 France Helicobacter Pylori Diagnostics Market, 2023 - 2030, USD Million
- TABLE 43 France Helicobacter Pylori Diagnostics Market by Test Type, 2019 - 2022, USD Million
- TABLE 44 France Helicobacter Pylori Diagnostics Market by Test Type, 2023 - 2030, USD Million
- TABLE 45 France Helicobacter Pylori Diagnostics Market by End User, 2019 - 2022, USD Million
- TABLE 46 France Helicobacter Pylori Diagnostics Market by End User, 2023 - 2030, USD Million
- TABLE 47 France Helicobacter Pylori Diagnostics Market by Method, 2019 - 2022, USD Million
- TABLE 48 France Helicobacter Pylori Diagnostics Market by Method, 2023 - 2030, USD Million
- TABLE 49 Russia Helicobacter Pylori Diagnostics Market, 2019 - 2022, USD Million
- TABLE 50 Russia Helicobacter Pylori Diagnostics Market, 2023 - 2030, USD Million
- TABLE 51 Russia Helicobacter Pylori Diagnostics Market by Test Type, 2019 - 2022, USD Million
- TABLE 52 Russia Helicobacter Pylori Diagnostics Market by Test Type, 2023 - 2030, USD Million
- TABLE 53 Russia Helicobacter Pylori Diagnostics Market by End User, 2019 - 2022, USD Million
- TABLE 54 Russia Helicobacter Pylori Diagnostics Market by End User, 2023 - 2030, USD Million
- TABLE 55 Russia Helicobacter Pylori Diagnostics Market by Method, 2019 - 2022, USD Million
- TABLE 56 Russia Helicobacter Pylori Diagnostics Market by Method, 2023 - 2030, USD Million
- TABLE 57 Spain Helicobacter Pylori Diagnostics Market, 2019 - 2022, USD Million
- TABLE 58 Spain Helicobacter Pylori Diagnostics Market, 2023 - 2030, USD Million
- TABLE 59 Spain Helicobacter Pylori Diagnostics Market by Test Type, 2019 - 2022, USD Million
- TABLE 60 Spain Helicobacter Pylori Diagnostics Market by Test Type, 2023 - 2030, USD Million
- TABLE 61 Spain Helicobacter Pylori Diagnostics Market by End User, 2019 - 2022, USD Million
- TABLE 62 Spain Helicobacter Pylori Diagnostics Market by End User, 2023 - 2030, USD Million
- TABLE 63 Spain Helicobacter Pylori Diagnostics Market by Method, 2019 - 2022, USD Million
- TABLE 64 Spain Helicobacter Pylori Diagnostics Market by Method, 2023 - 2030, USD Million
- TABLE 65 Italy Helicobacter Pylori Diagnostics Market, 2019 - 2022, USD Million
- TABLE 66 Italy Helicobacter Pylori Diagnostics Market, 2023 - 2030, USD Million
- TABLE 67 Italy Helicobacter Pylori Diagnostics Market by Test Type, 2019 - 2022, USD Million
- TABLE 68 Italy Helicobacter Pylori Diagnostics Market by Test Type, 2023 - 2030, USD Million
- TABLE 69 Italy Helicobacter Pylori Diagnostics Market by End User, 2019 - 2022, USD Million
- TABLE 70 Italy Helicobacter Pylori Diagnostics Market by End User, 2023 - 2030, USD Million
- TABLE 71 Italy Helicobacter Pylori Diagnostics Market by Method, 2019 - 2022, USD Million
- TABLE 72 Italy Helicobacter Pylori Diagnostics Market by Method, 2023 - 2030, USD Million
- TABLE 73 Rest of Europe Helicobacter Pylori Diagnostics Market, 2019 - 2022, USD Million
- TABLE 74 Rest of Europe Helicobacter Pylori Diagnostics Market, 2023 - 2030, USD Million
- TABLE 75 Rest of Europe Helicobacter Pylori Diagnostics Market by Test Type, 2019 - 2022, USD Million
- TABLE 76 Rest of Europe Helicobacter Pylori Diagnostics Market by Test Type, 2023 - 2030, USD Million
- TABLE 77 Rest of Europe Helicobacter Pylori Diagnostics Market by End User, 2019 - 2022, USD Million
- TABLE 78 Rest of Europe Helicobacter Pylori Diagnostics Market by End User, 2023 - 2030, USD Million
- TABLE 79 Rest of Europe Helicobacter Pylori Diagnostics Market by Method, 2019 - 2022, USD Million
- TABLE 80 Rest of Europe Helicobacter Pylori Diagnostics Market by Method, 2023 - 2030, USD Million
- TABLE 81 Key Information - Biohit Oyj
- TABLE 82 Key Information - Gulf Coast Scientific, Inc.
- TABLE 83 Key Information - Meridian Bioscience, Inc.
- TABLE 84 Key Information - Avanos Medical, Inc.
- TABLE 85 Key Information - Abbott Laboratories
- TABLE 86 Key Information - Thermo Fisher Scientific, Inc.
- TABLE 87 KEY INFORMATION - F. Hoffmann-La Roche Ltd.
- TABLE 88 key information - Quidel Corporation
- TABLE 89 key information - Cardinal Health, Inc.
- TABLE 90 Key Information - Bio-Rad Laboratories, Inc.
List of Figures
- FIG 1 Methodology for the research
- FIG 2 Europe Helicobacter Pylori Diagnostics Market share by Test Type, 2022
- FIG 3 Europe Helicobacter Pylori Diagnostics Market share by Test Type, 2030
- FIG 4 Europe Helicobacter Pylori Diagnostics Market by Test Type, 2019 - 2030, USD Million
- FIG 5 Europe Helicobacter Pylori Diagnostics Market share by End User, 2022
- FIG 6 Europe Helicobacter Pylori Diagnostics Market share by End User, 2030
- FIG 7 Europe Helicobacter Pylori Diagnostics Market by End User, 2019 - 2030, USD Million
- FIG 8 Europe Helicobacter Pylori Diagnostics Market share by Method, 2022
- FIG 9 Europe Helicobacter Pylori Diagnostics Market share by Method, 2030
- FIG 10 Europe Helicobacter Pylori Diagnostics Market by Method, 2019 - 2030, USD Million
- FIG 11 Europe Helicobacter Pylori Diagnostics Market share by Country, 2022
- FIG 12 Europe Helicobacter Pylori Diagnostics Market share by Country, 2030
- FIG 13 Europe Helicobacter Pylori Diagnostics Market by Country, 2019 - 2030, USD Million
- FIG 14 Swot analysis: Abbott laboratories
- FIG 15 Swot analysis: thermo fisher scientific, inc.
